Biotechnology in China

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 81
Appendixes

OCR for page 81

OCR for page 81
A Abbreviations CAPM Chinese Academy of Preventive Medicine CAS Chinese Academy of Sciences Academia Sinica) CHO Chinese hamster ovary (cell line) CMV cucwnber mosaic virus CNCBD China National Center for Biotechnology Development CSCPRC Committee on Scholarly Communication win the People's Republic of China DAFT dihydrofolate reductive BsAg hepadds B surface antigen HBV hepatitis B virus NAS National Academy of Sciences ~J.S.A.) NSF National Science Foundation (U.S.A.) NSFC National Natural Science Foundation of China SEDC State Education Commission SSTC State Science and Technology Commission Ti plasmid No-inducing plasmid TMV tobacco mosaic virus 83

Table of Contents

Front Matter R1-R14

1. Introduction 1-2

2. China's Long History of Biotechnology 3-5

3. Research Priorities and Funding Mechanisms 6-14

4. New Research Centers 15-17

5. Infrastructure 18-21

6. Biotechnology Literature Survey 22-31

7. Research Highlights 32-39

8. Current Research at Selected Institutes 40-67

9. Cooperation with the United States 68-74

10. Conclusions and Recommendations 75-80

Appendix A: Abbreviations 81-83

Appendix B: Contacts - Scientific Administration 84-85

Appendix C: Contacts - Research Institutes and Universities 86-91

Appendix D: An Analysis of Niu Menchang's Research on Transformation by RNA 92-96

Appendix E: Statement by Dr. Niu 97-102